A recent study on human lung cancer cell lines showed that arvanil combined with irinotecan produced synergistic interactions in H69-CPR and PC9-CDDP, i.e., cisplatin-resistant lung cancer cells [34]. The gene discussed is POR; the disease is lung carcinoma.